Results 251 to 260 of about 2,024,119 (265)

Anti-MRSA cephalosporins Bristol-Myers Squibb.

Current opinion in investigational drugs (London, England : 2000), 2002
BMS is investigating a series of cephalosporins for potential use in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection [274213]. In vitro activity tests resulted in a minimum inhibitory concentration (MIC) of 1 to 8 microg/ml against MRSA 1274213].
openaire   +1 more source

Syntheses and anti-MRSA activities of the C3 analogs of mansonone F, a potent anti-bacterial sesquiterpenoid: insights into its structural requirements for anti-MRSA activity

Bioorganic and Medicinal Chemistry Letters, 2004
Seok-Ho Kim, Young-Ger Suh, Jae M Jeong
exaly  

In vitro and in vivo anti-MRSA activities of nosokomycins

Drug Discoveries and Therapeutics, 2014
Hidenori Matsui, Masato Iwatsuki, Hiroshi Hamamoto   +2 more
exaly  

The structure–activity relationships of mansonone F, a potent anti-MRSA sesquiterpenoid quinone: SAR studies on the C6 and C9 analogs

Bioorganic and Medicinal Chemistry Letters, 2006
Soonsil Hyun, Young-Ger Suh, Dong-Yun Shin   +2 more
exaly  

Anti-Infectious Agents against MRSA

Molecules, 2013
Hiroshi Tomoda, Nobuhiro Koyama, Junji Inokoshi   +2 more
exaly  

Emodin is identified as the active component of ether extracts from Rhizoma Polygoni Cuspidati, for anti-MRSA activity

Canadian Journal of Physiology and Pharmacology, 2015
Wei Peng, Xichun Pan
exaly  

Design and synthesis via click chemistry of 8,9-anhydroerythromycin A 6,9-hemiketal analogues with anti-MRSA and -VRE activity

Bioorganic and Medicinal Chemistry Letters, 2007
Satoshi Omura, Kenichiro Nagai, Akihiro Sugawara   +2 more
exaly  

ANTI-MRSA COMPOSITION.

1995
YONETA TOSHIO MEIJI SEIKA KABU, FUJII NAOYUKI BIOMATERIAL CO L, OOISHI MAKI MEIJI SEIKA KABUSH, IINUMA KATSUHARU MEIJI SEIKA K, SATO ATSUYUKI MEIJI SEIKA KABU, YASUDA KIMIAKI BIOMATERIAL CO   +5 more
openaire   +1 more source

Prenylated flavonoids from and evaluation of their anti-MRSA activity

Phytochemistry, 2012
Yoshiki Kashiwada, Hirofumi Shibata, Yoshihisa Takaishi   +2 more
exaly  

Bottromycin derivatives: Efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities

Bioorganic and Medicinal Chemistry Letters, 2010
Hirokazu Takada, Rokuro Masuma, Atsuko Matsumoto   +2 more
exaly